Emmaus Life Sciences, Inc. Equity Method Investments
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments
us-gaap:EquityMethodInvestments · last filed 2024-07-03
- 2023-09-30: Equity Method Investments $17.74M.
- 2023-06-30: Equity Method Investments $18.30M.
- 2023-03-31: Equity Method Investments $19.11M.
- 2022-12-31: Equity Method Investments $18.83M.
| Period end | Equity Method Investments |
|---|---|
| 2023-09-30 | $17.74M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $18.30M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $19.11M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $18.83M 10-K · filed 2024-07-03 |
| 2022-09-30 | $16.59M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $16.98M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $17.77M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $17.62M 10-K · filed 2023-03-31 |
| 2021-09-30 | $17.84M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $17.38M 10-Q · filed 2021-09-01 |
| 2021-03-31 | $15.79M 10-Q · filed 2021-09-01 |
| 2020-12-31 | $15.93M 10-K · filed 2022-03-31 |
| 2020-09-30 | $14.48M 10-Q · filed 2021-08-26 |
| 2020-06-30 | $13.01M 10-Q · filed 2021-08-26 |
| 2020-03-31 | $12.98M 10-Q · filed 2021-08-26 |
| 2019-12-31 | $13.32M 10-Q · filed 2021-08-26 |